BlackRock, Inc. 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BlackRock Inc. BLK |
31,238 2.100% |
-63,952 (-67.18%) |
Filing |
| 2023-02-06 3:34 pm Purchase |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BlackRock Inc. BLK |
95,190 6.500% |
12,758 (+15.48%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BlackRock Inc. BLK |
82,432 7.300% |
3,256 (+4.11%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BlackRock Inc. BLK |
79,176 7.300% |
16,186 (+25.70%) |
Filing |